MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • White Papers
  • DeviceTalks

Elekta picks up radiology QA software dev Acumyn

July 31, 2018 By Fink Densford Leave a Comment

Elekta (STO:EKTA B) said late last week it acquired Canadian quality assurance company Acumyn for an undisclosed amount. Acumyn, which spun-out of Toronto’s University Hospital Network, was started to commercialize the Aqua software platform. Aqua is intended to coordinate, centralize and automate all QA tests that need to be performed in radiotherapy clinics, Elekta said. “This […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Software / IT Tagged With: acumyn, Elekta

York Instruments picks up Elekta’s MEG biz

July 25, 2018 By Brad Perriello Leave a Comment

Croton Healthcare subsidiary York Instruments said today that it’s buying the magnetoencephalography business at Elekta (STO:EKTA B) for an undisclosed amount. The MEG technology is designed to map brain activity in clinical and research settings. Elekta’s MEGIN business put up sales of about $11.6 million last year (SEK102 million). Get the full story at our sister site, Medical […]

Filed Under: Imaging, Mergers & Acquisitions, Wall Street Beat Tagged With: Elekta, York Instruments

Elekta wins CE Mark for Unity high-field MR-linac

June 18, 2018 By Fink Densford Leave a Comment

Elekta (STO:EKTA B) said today it won CE Mark approval in the European Union for its Elekta Unity magnetic resonance radiation therapy system. The Stockholm-based company touted that its Unity system allows clinicians to deliver radiation doses while simultaneously visualizing the tumor and surrounding tissue through MR imaging. The system also features integrated advanced tools […]

Filed Under: Imaging, Oncology, Regulatory/Compliance Tagged With: Elekta

Brainlab releases VersaHD high-res planning algorithm

April 20, 2018 By Fink Densford Leave a Comment

Brainlab said today it launched a new high-res planning algorithm within its Brainlab Elements software to improve radiation dose conformity for treating brain tumors, and added that the algorithm is a result of its strategic collaboration Elekta (STO:EKTA B). The Munich-based company’s Elements system operates with Elekta’s Agility multileaf collimator to compensate for the width of […]

Filed Under: Business/Financial News, Oncology, Radiosurgery/Radiation therapy, Software / IT Tagged With: Brainlab, Elekta

Zimmer Biomet picks ex-Covidien exec Lannum for IR chief | Personnel Moves – March 20, 2018

March 20, 2018 By Fink Densford Leave a Comment

Zimmer Biomet (NYSE:ZBH) said yesterday it tapped former Covidien investor relations head Coleman Lannum as its investor relations senior VP, reporting directly to prez & CEO Bryan Hanson. Lannum has more than 15 years in investor relations, having held positions with Mallinckrodt Pharmaceuticals (NYSE:MNK), Covidien and Tyco Healthcare. During his time with Covidien, Lannum oversaw the company’s initial […]

Filed Under: Business/Financial News Tagged With: Biocoat, Cogmedix, Covidien, Draeger Medical, Elekta, EMC Corp., Imaging3, imetechnologies, Mallinckrodt, Medtronic, Personnel Moves, Siemens, Sight Sciences, Tyco Healthcare, Varex Imaging, Zimmer Biomet

Elekta inks oncology co-selling deal with IBM Watson Health

January 31, 2018 By Fink Densford Leave a Comment

Elekta (STO:EKTA B) said today it inked a collaborative sales deal with IBM‘s (NYSE:IBM) Watson Health through which Elekta will offer IBM’s Watson for Oncology with its cancer care solutions. With the deal, Elekta said it will begin offering the Watson for Oncology early this year as a clinical decision support solution paired with its digital cancer […]

Filed Under: Business/Financial News, Oncology Tagged With: Elekta, IBM Watson Health

Elekta taps Brainlab as US stereotactic neurosurgery distro partner

December 13, 2017 By Fink Densford Leave a Comment

Elekta (STO:EKTA B) said today it inked an exclusive deal with Brainlab to make it the authorized distributor of Elekta’s stereotactic neurosurgery solutions. Through the deal, Brainlab will be the authorized distributor of Elekta’s Leksell Vantage stereotactic system which won CE Mark approval in the European Union this year. The system also has FDA 510(k) clearance […]

Filed Under: Business/Financial News, Distribution, Neurological Tagged With: Brainlab, Elekta

Elekta delays rollout for Unity MR-radiation therapy combo

November 30, 2017 By Brad Perriello Leave a Comment

Elekta (STO:EKTA B) today said it’s delaying the rollout of its Unity device, designed to combine magnetic resonance imaging with a linear accelerator for radiation therapy, saying it needs more time to finalize and validate the linac control system. The Swedish company said the decision means it’s postponing its bid for CE Mark approval in the […]

Filed Under: Imaging, MassDevice Earnings Roundup, Radiosurgery/Radiation therapy, Wall Street Beat Tagged With: Elekta

Elekta inks stereotactic development, software, co-marketing deals

September 25, 2017 By Alex Beall Leave a Comment

Medical software and equipment company Elekta has signed separate deals with Ion Beam Applications and Brainlab to share and integrate their technologies. In the memorandum of understanding with Ion Beam Applications, the two companies agreed to collaborate on investment in software development and the sale and marketing of each other’s products through a joint portfolio. […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Elekta

Elekta taps Brainlab as select EU distro partner for stereotactic neuro devices

June 29, 2017 By Fink Densford Leave a Comment

Elekta (STO:EKTA B) said today it tapped Brainlab to distribute its stereotactic neurological devices across select markets in the European Union. The distribution agreement covers Elekta’s Leksell Vantage Steretactic target localization and coordinate referencing neurosurgery system, the company said, which received CE Mark approval in the EU in March. The device is currently pending 510(k) clearance […]

Filed Under: Business/Financial News, Distribution, Neurological, Surgical Tagged With: Brainlab, Elekta

Feds charge ex-Medicare employees with insider trading

May 24, 2017 By Brad Perriello Leave a Comment

Former employees at the Centers for Medicare & Medicaid Services used confidential information on Medicare reimbursement changes for radiation treatments and dialysis in a nearly $4 million insider trading scheme, federal prosecutors and the U.S. Securities & Exchange Commission alleged today. An SEC lawsuit and a criminal complaint accuse political consultant David Blaszczak, founder of Precipio Health Strategies […]

Filed Under: Wall Street Beat Tagged With: DaVita Inc., Elekta, Fresenius, Insider Trading, Varian Medical Systems

  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS